Inhibition of intestinal calcium transport by antidiabetic biguanides.
D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D002026:Buformin / Q000494:pharmacology; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004386:Duodenum / Q000378:metabolism*; D005260:Female; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000378:metabolism*; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D010629:Phenformin / Q000494:pharmacology; D051381:Rats
D001645:Biguanides; D007004:Hypoglycemic Agents; D010629:Phenformin; D002118:Calcium; D002026:Buformin